A share price of Hims & Hers Health Inc [HIMS] is currently trading at $21.77, down -6.37%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The HIMS shares have gain 12.10% over the last week, with a monthly amount glided 0.97%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on May 22, 2024, when Citigroup downgraded its rating to a Neutral and also boosted its price target to $20 from $16. Previously, Jefferies downgraded its rating to Hold on April 16, 2024, and dropped its price target to $15. On April 10, 2024, Canaccord Genuity initiated with a Buy rating and assigned a price target of $20 on the stock. Imperial Capital upgraded its rating to a Outperform but stick to its price target of $16 on February 28, 2024. Leerink Partners initiated its recommendation with a Market Perform and recommended $10 as its price target on February 26, 2024. Imperial Capital started tracking with a In-line rating for this stock on December 07, 2023, and assigned it a price target of $9. In a note dated July 28, 2023, TD Cowen initiated an Outperform rating and provided a target price of $11 on this stock.
Hims & Hers Health Inc experienced fluctuations in its stock price throughout the past year between $5.65 and $25.74. Currently, Wall Street analysts expect the stock to reach $13.29 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $21.77 at the most recent close of the market. An investor can expect a potential drop of -38.95% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
Trailing Twelve Months sales for Hims & Hers Health Inc [NYSE:HIMS] were 959.40M which represents 45.81% growth. Gross Profit Margin for this corporation currently stands at 0.82% with Operating Profit Margin at -0.02%, Pretax Profit Margin comes in at 0.0%, and Net Profit Margin reading is -0.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.01 and Total Capital is -0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 20.67 points at the first support level, and at 19.58 for the second support level. However, for the 1st resistance point, the stock is sitting at 23.55, and for the 2nd resistance point, it is at 25.34.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Hims & Hers Health Inc [NYSE:HIMS] is 2.80. Also, the Quick Ratio is 2.48, while the Cash Ratio stands at 1.13. Considering the valuation of this stock, the price to sales ratio is 4.87, the price to book ratio is 13.55.
Transactions by insiders
Recent insider trading involved Chi Michael, Chief Commercial Officer, that happened on Jul 24 ’24 when 17303.0 shares were sold. Chief Commercial Officer, Chi Michael completed a deal on Jul 23 ’24 to sell 7500.0 shares. Meanwhile, Chief Legal Officer Boughton Soleil sold 2335.0 shares on Jul 23 ’24.
